Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women is a research paper published in Journal of the International AIDS Society (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Mental Health
Grant: UM1AI068619
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068614
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068618
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068635
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: UM1AI068613
NIAID NIH HHS
Grant: U01 AI069436
NIAID NIH HHS
Grant: UM1 AI068617
NIAID NIH HHS
Grant: UM1 AI069456
NIAID NIH HHS
Grant: UM1 AI069463
NIAID NIH HHS
Grant: UM1 AI069423
NIAID NIH HHS
Grant: UM1 AI069436
United States Agency for International Development
PEPFAR
National Institute on Drug Abuse
South African Medical Research Council
Bill and Melinda Gates Foundation
National Institute of Allergy and Infectious Diseases
MeSH Terms
Keywords